Rituximab for children with EBV-positive Burkitt lymphoma in East Africa

Rituximab for children with EBV-positive Burkitt lymphoma in East Africa

Abstract: The addition of rituximab to the chemotherapy backbone was shown to significantly improve outcomes of children with aggressive high-grade lymphomas in high-income countries. However, data on its safety and efficacy in children with Epstein-Barr virus (EBV)–positive Burkitt lymphoma (BL) ar...

Full description

Saved in:
Bibliographic Details
Main Authors: William Frank Mawalla, Caroline Achola, Hadijah Nabalende, Isaac Otim, Ismail D. Legason, Martin D. Ogwang, Pamella M. Aol, Godlove Sandi, Hadija Mwamtemi, Salama Mahawi, Elifuraha Mkwizu, Philomena G. Lyamuya, Jacqueline P. Kamanga, Kristin Schroeder, Paul Ntemi, Clara Chamba, Dimitris Vavoulis, Liz Morrell, Lulu Chirande, Anna Schuh
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952925001223
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items